Catalyst Wire Dossier Catalyst Wire Dossier

SA001

· Samjin Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SA001, covering 2022-03-18 to 2023-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome [Phase 2]

See pricing